Iterum Therapeutics plc (ITRMF) Short term Debt (2018 - 2024)

Iterum Therapeutics has reported Short term Debt for 5 years, with the latest figure at $14.5 million in Q4 2024.

• On a quarterly basis, Short term Debt changed N/A year-over-year to $14.5 million in Q4 2024; TTM through Dec 2024 was $14.5 million, a N/A change from a year earlier, with the FY2024 full-year figure at $14.5 million, changed N/A from the prior year.
• Short term Debt was $14.5 million for Q4 2024 at Iterum Therapeutics, up from $13.7 million in the prior quarter.
• The five-year high for Short term Debt was $14.5 million in Q4 2024, with the low at $1.6 million in Q4 2021.
• Average Short term Debt over 3 years is $7.8 million, with a median of $6.2 million recorded in 2020.
• The sharpest annual moves came in 2020 and 2021: Short term Debt jumped 185.36% in 2020, then tumbled 74.47% in 2021.
• Over 3 years, Short term Debt stood at $6.4 million in 2020, then sank by 74.47% to $1.6 million in 2021, then jumped by 788.94% to $14.5 million in 2024.
• The last three Short term Debt figures came in at $14.5 million (Q4 2024), $13.7 million (Q3 2024), and $13.0 million (Q2 2024), per Business Quant data.